PI @CRUK_CI @Cambridge_uni, @UKRI_News FLF, co-lead @CRUKCamPancCan. giuliabiffi.bsky.social
Cambridge, England
- Tweets 1,198
- Following 524
- Followers 2,817
- Likes 2,362
Pinned Tweet
🎉Our paper on #PDAC and #Pancreatitis organoid multistroma #cocultures is on the cover of @NatureCellBio! Congratulations to the whole lab!!
Almost 10 years (🤯) after my postdoc paper in @JExpMed, here we are again!! So poetic!
nature.com/articles/s41556-0…
5
11
69
3,612
🚨Happy to share with you our Lab’s latest #BioRxiv pre-print. 🥳
TGF-β- and IL-1-dependent fibroblast states differentially shape pancreatic cancer microenvironments and metastasis
biorxiv.org/content/10.64898…
A huge amount of work (and 🐭 breedings!).
Hope you enjoy the read!
1
10
42
2,637
🥳Happy to share our latest manuscript - out today in @NatureCellBio.
💜 Congrats and thanks to @Wenlong_Li1 and @Munta04, the whole lab, our collaborators and the funders that supported this important and beautiful 🤩 work!
Hope you enjoy the read!
nature.com/articles/s41556-0…
2
9
72
6,247
Giulia Biffi retweeted
🔥🔥🔥
DARAXONRASIB APPROVED FOR METASTATIC #PancreaticCancer
fda.gov/news-events/press-an…
3
47
151
11,344
Cool stuff @DannieEngle 😊
Great work by @DannieEngle @salkinstitute building ex vivo models in a neglected disease of the pancreas - chronic pancreatitis.
cell.com/cell-stem-cell/full…
One key finding - half of pancreatitis organoids have CFTR dysfunction, even ones with wild type gene, amenable to therapy.
1
9
1,233
Giulia Biffi retweeted
Last week, our CEO attended @CR_UK's inaugural #PancreaticCancer Conference, bringing together researchers working to improve earlier diagnosis and outcomes.
Progress like this gives hope for the future. 💜
See how we make a difference: pancreaticcanceraction.org/
#CancerAwareness
1
7
238
The inaugural #CRUK #PanConf26 may be over but I suspect it will not be the last one…😉
And this is thanks to all the people that made this happen, especially @TaraMcKay20, our 350+ attendees (>60% from outside the UK) and my wonderful co-organizers @Aiims1742 and @SaurLab!
3
19
1,724
Thank you @Aiims1742 for the excellent chairing and a great talk.
The @CR_UK #PanConf26 was proof how much great science is happening in #PancreaticCancer in the UK & rest of Europe. Now is the time for greater international collaborations with our partners across the Atlantic. Really enjoyed my time in London!
Thanks to @BristiBasu8 for 📸
9
1,097
Giulia Biffi retweeted
The @CR_UK #PanConf26 was proof how much great science is happening in #PancreaticCancer in the UK & rest of Europe. Now is the time for greater international collaborations with our partners across the Atlantic. Really enjoyed my time in London!
Thanks to @BristiBasu8 for 📸
3
12
43
3,569
Thank you for the excellent talk and for the excellent company @IamLinghua !
1
8
1,184
Look at that room! 🤩
Thanks to @Aiims1742 and @SaurLab for being the best co-organizers I could have wished for this inaugural meeting🔝
Very grateful for all your time and dedication despite being so busy.
Very grateful to @TaraMcKay20 and all session chairs too🤩
#PanConf26
Ready to start Day 2 of the inaugural @CR_UK #PancreaticCancer conference!
Thanks to co-organizers @BiffiGiulia & @SaurLab, and the @CRUKresearch team for putting this wonderful meeting together. The conference hashtag is #PanConf26
@TaraMcKay20 @lgoodbu
2
14
1,053
🎉Ready for Day 2 #PanConf26 🎉
Great to catch up with colleagues but also lovely to hang out outside the lab with my favourite postdocs (= all the current Lab’s postdocs 😅).
@Debi_Mukh @eloise_g_lloyd @Wenlong_Li1 #GianlucaMucciolo
2
15
832
🎉 Day 1 of the inaugural #CRUK #PancreaticCancer conference is here 🎉
Thank you to @Aiims1742 @SaurLab @TaraMcKay20 and our session chairs for help shaping a fantastic programme!
4
22
10,492
Giulia Biffi retweeted
The Cambridge South station has arrived on time 🚆
Opened to the public last Sunday, the @networkrail station can receive over 1.8 million journeys in a year. This will be invaluable to the @CamBioCampus and the University of Cambridge. The Campus is the city's largest employment site, where over 22,000 people work 🧑🔬
This will not only make commuting easier for many workers, it will also benefit those visiting the Campus to seek treatment or find research and investment opportunities.
Have you got off at this new stop? Let us know how much time it has saved you👇
1
29
96
11,792
Great to see our #Review out in @Cancer_Cell. A true pleasure to work with @HHuanglab and all other authors I am a big fan of! ⭐️
Hope you enjoy this treat as much as we enjoyed it! 🤗
Excited to share our new Review on CAFs! A true collective effort with so many brilliant colleagues @BiffiGiulia @akshayk25 @FatimaMechta @shouval @MaraShermanLab @TurleyLabGNE @IamLinghua . Honored to be part of this journey! cell.com/cancer-cell/fulltex…
15
1,653
Giulia Biffi retweeted
During the panel at @CancerGrand Conference: Cancer and the host. we explored the relationships between cancer, obesity, diet, metabolism, cancer, and therapy. Thanks @EileenWhitePhD @ThalesPapaG @StephenORahilly for sharing your wisdom. #fullhouse
1
4
15
1,207
Giulia Biffi retweeted
Our next round of Project Grants is now open for applications! These awards will support bold, pioneering, collaborative #PancreaticCancer research.
Awards of up to £330,000 are available for a maximum of three years.
Find out more and apply: bit.ly/432ILUP
ALT A person wearing gloves holds a microscope slide. Text on a purple background reads: "Project Grants. Now open for application. Deadline: 6th August 2025.”
3
3
471
Presented at #ASCO26:
Among patients with previously treated metastatic pancreatic ductal adenocarcinoma, the RAS(ON) inhibitor daraxonrasib led to significantly longer overall survival and progression-free survival than chemotherapy. Full phase 3 RASolute 302 trial results: nej.md/4nWaxvM
@ASCO
ALT Graph from a study published in the New England Journal of Medicine on daraxonrasib versus chemotherapy for metastatic pancreatic cancer. The x-axis represents months, and the y-axis shows the percentage of patients alive. Two lines indicate survival rates: daraxonrasib (blue) and chemotherapy (gray). The bottom section lists patients at risk over time. Title and journal logo are included.
52
2,040
5,567
2,632,088
#PancreaticCancer, your days are numbered with this #team. 💜
2
10
528
🎉 Very happy to have had the opportunity to contribute to this latest @DiseasePrimers #Review on #PancreaticCancer together with a number of great colleagues! @ednacukierman @EileenMOReilly @SaurLab @BarbaraGrnwald ...
Hope it is a useful read! 😊💜
nature.com/articles/s41572-0…
7
29
1,631